Aerie Pharmaceuticals, Inc. (AERI): Price and Financial Metrics

Aerie Pharmaceuticals, Inc. (AERI)

Today's Latest Price: $19.01 USD

0.44 (-2.26%)

Updated Feb 18 8:00pm

Add AERI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AERI Stock Summary

  • AERI's price/sales ratio is 19.04; that's higher than the P/S ratio of 93.79% of US stocks.
  • With a year-over-year growth in debt of 1,080.55%, Aerie Pharmaceuticals Inc's debt growth rate surpasses 97.43% of about US stocks.
  • As for revenue growth, note that AERI's revenue has grown 513.75% over the past 12 months; that beats the revenue growth of 98.61% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Aerie Pharmaceuticals Inc are FLXN, PRTK, YY, IBIO, and RNWK.
  • AERI's SEC filings can be seen here. And to visit Aerie Pharmaceuticals Inc's official web site, go to
AERI Daily Price Range
AERI 52-Week Price Range

AERI Stock Price Chart More Charts

AERI Price/Volume Stats

Current price $19.01 52-week high $50.10
Prev. close $19.45 52-week low $17.15
Day low $18.58 Volume 813,800
Day high $19.55 Avg. volume 740,928
50-day MA $22.33 Dividend yield N/A
200-day MA $24.78 Market Cap 880.56M

Aerie Pharmaceuticals, Inc. (AERI) Company Bio

Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The company was founded in 2005 and is based in Irvine, California.

AERI Latest News Stream

Event/TimeNews Detail
Loading, please wait...

AERI Latest Social Stream

Loading social stream, please wait...

View Full AERI Social Stream

AERI Price Returns

1-mo N/A
3-mo 3.32%
6-mo -18.83%
1-year -53.41%
3-year -57.61%
5-year -31.40%
YTD -21.35%
2019 -33.05%
2018 -39.58%
2017 57.86%
2016 55.44%
2015 -16.58%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7029 seconds.